Not applicableStudy completedNCT04566510What this trial is testingLLIN Evaluation in Uganda ProjectWho this might be right forMalaria University of California, San Francisco 32,895
Testing effectiveness (Phase 2)UnknownNCT02294006What this trial is testingActivity and Safety of Everolimus+Octreotide LAR+Metformin in Advanced Pancreatic Well-differentiated NETsWho this might be right forWell Differentiated Pancreatic Endocrine Tumor Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 26
Post-approval studies (Phase 4)UnknownNCT01697852What this trial is testingThe Combined Use of Indoor Residual Spraying (IRS) and Long-lasting Insecticidal Nets (LLINs) for Malaria PreventionWho this might be right forMalaria London School of Hygiene and Tropical Medicine 22,300
Early research (Phase 1)Active Not RecruitingNCT04234568What this trial is testingTesting the Addition of an Anti-cancer Drug, Triapine, to the Usual Radiation-Based Treatment (Lutetium Lu 177 Dotatate) for Neuroendocrine TumorsWho this might be right forMetastatic Digestive System Neuroendocrine NeoplasmMetastatic Neuroendocrine Tumor National Cancer Institute (NCI) 31
Testing effectiveness (Phase 2)Active Not RecruitingNCT03891784What this trial is testingAbemaciclib in Treating Patients With Advanced, Refractory, and Unresectable Digestive System Neuroendocrine TumorsWho this might be right forAdvanced Digestive System Neuroendocrine NeoplasmDigestive System Neuroendocrine TumorForegut Neuroendocrine Tumor+6 more University of Washington 20
Testing effectiveness (Phase 2)Study completedNCT03722511What this trial is testingEvaluating an Amino Acid Based Medical Food w/ Diarrhea in Carcinoid Syndrome & Other NETsWho this might be right forNeuroendocrine TumorsCarcinoid Tumor of GI SystemDiarrhea+1 more Lowell Anthony, MD 10
Not applicableStudy completedNCT02564393What this trial is testingInduction of Neutrophilic Traps ( NETs ) by the Environment and Infectious Inflammatory Lung Cystic FibrosisWho this might be right forCystic Fibrosis University Hospital, Tours 55
Large-scale testing (Phase 3)Active Not RecruitingNCT04919226What this trial is testingLutetium 177Lu-Edotreotide Versus Best Standard of Care in Well-differentiated Aggressive Grade-2 and Grade-3 GastroEnteroPancreatic NeuroEndocrine Tumors (GEP-NETs) - COMPOSEWho this might be right forNeuroendocrine Tumors ITM Solucin GmbH 259
Not applicableStudy completedNCT04696042What this trial is testingAsian Investigation of Lanreotide Autogel® in the Management of GEP-NETsWho this might be right forNeuroendocrine Tumors Asan Medical Center 71
Testing effectiveness (Phase 2)Study completedNCT02299089What this trial is testingPhase II Study of Subcutaneous Inj. Depot of Octreotide in Patients With Acromegaly and Neuroendocrine Tumours (NETs)Who this might be right forAcromegalyNeuroendocrine Tumors Camurus AB 12
Early research (Phase 1)Study completedNCT01364415What this trial is testingDose Escalation Study of Pasireotide (SOM230) in Patients With Advanced Neuroendocrine Tumors (NETs)Who this might be right forNeuroendocrine Tumors Novartis Pharmaceuticals 29
Testing effectiveness (Phase 2)Study completedNCT04362436What this trial is testingTheraSphere Selective Internal Radiation Therapy (SIRT) as Treatment for Neuroendocrine Tumours With Liver MetsWho this might be right forNeuroendocrine TumorsLiver Metastases Imperial College London 24
Not applicableActive Not RecruitingNCT03498040What this trial is testingDevelopment and Progression of Carcinoid Heart Disease in a Cohort of Adult Patients With Neuroendocrine TumorsWho this might be right forCarcinoid Heart Disease Hospices Civils de Lyon 670
Not applicableActive Not RecruitingNCT05064150What this trial is testingNeuroendocrine Tumors - Patient Reported OutcomesWho this might be right forNeuroendocrine TumorsGastroenteropancreatic Neuroendocrine TumorLung Neuroendocrine Neoplasm+1 more University of Iowa 2,539
Not applicableNot Yet RecruitingNCT06607198What this trial is testingClinical-pathological Evaluation of Pit-NETsWho this might be right forPituitaryCancerNeuroendocrine Tumors Fondazione Policlinico Universitario Agostino Gemelli IRCCS 940
Post-approval studies (Phase 4)Study completedNCT01595009What this trial is testingAn Open-label, Multi-center, Expanded Access Study of Everolimus in Participants With Advanced Neuroendocrine Tumors (NETs) (Core Study) and an Extension Study to the Open-label, Multi-center, Expanded Access Study of Everolimus in Patients With Advanced NETs (E1)Who this might be right forNeuroendocrine Tumors Novartis Pharmaceuticals 246
Early research (Phase 1)Active Not RecruitingNCT05249114What this trial is testingStudy of Cabozantinib With Lu-177 in Patients With Somatostatin Receptor 2 Positive Neuroendocrine TumorsWho this might be right forNeuroendocrine Tumors Providence Health & Services 6
Large-scale testing (Phase 3)Looking for participantsNCT06784752What this trial is testingStudy to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NETWho this might be right forSomatostatin Receptor Positive (SSTR+)Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET) Novartis Pharmaceuticals 240
Not applicableWithdrawnNCT03895463What this trial is testingStudy to Assess the Use of Lanreotide Autogel® 120 mg in Patients With Locally Advanced or Metastatic Gastroenteropancreatic Neuroendocrine Tumours (GEP-NETs) in Routine Clinical PracticeWho this might be right forNeuroendocrine Tumors Ipsen
Not applicableStudy completedNCT04157894What this trial is testingEstimating the Malaria Prevention Impact of New Nets: Observational Analyses to Evaluate the Evidence Generated During Piloted New Net Distributions in Burkina FasoWho this might be right forMalaria PATH 5,606